PM226 is a selective cannabinoid CB2R agonist ( K i (CB2R) =13 nM; EC 50 (CB2R) =39 nM; K i (CB1R) >40 μM;) with neuroprotective properties in vitro and vivo.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Cannabinoid Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.